Literature DB >> 6218347

Suppressor T cells in B-cell chronic lymphocytic leukaemia: relationship to clinical stage.

K H Mills, J C Cawley.   

Abstract

In 32 patients with B-cell chronic lymphatic leukaemia (CLL), OKT8+ suppressor T cells were increased in relative (mean 54 +/- 14%; normal mean 34 +/- 6%) and absolute (1.8 +/- 1.6 X 10(9)/1; normal range 0.3-0.6 X 10(9)/1) numbers. OKT4+ helper cells were reduced in relative (mean 53 +/- 15%; normal mean 65 +/- 7%) but not absolute (1.7 +/- 1.4 X 10(9)/1; normal range 0.6-1.4 X 10(9)/1) numbers. Essentially identical results were obtained in treated and untreated patients. There was no significant association between T-cell subset numbers and clinical stage, whether assessed by the Rai classification or the more recent Binet system, although the OKT4+/8+ ratio was slightly lower in advanced disease. The study suggests that the immunoparesis so characteristic of CLL may be attributable to increased suppressor T-cell activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218347     DOI: 10.1016/0145-2126(82)90081-9

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  Cytotoxic lymphocytes in B-cell chronic lymphocytic leukemia. A flow cytometric study of peripheral blood, lymph nodes and bone marrow.

Authors:  L W Terstappen; B G de Grooth; I Segers-Nolten; J Greve
Journal:  Blut       Date:  1990-02

2.  Flow cytometric analysis of T-lymphocyte subpopulations in B-cell chronic lymphocytic leukemia: correlation with clinical stage.

Authors:  M L Hautekeete; R F De Bock; D R Van Bockstaele; G C Colpin; Z N Berneman; M E Peetermans
Journal:  Blut       Date:  1987-11

3.  Defective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukaemia.

Authors:  R A Knight; C P Worman; J C Cawley
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  T cell subpopulations in B cell chronic lymphocytic leukaemias.

Authors:  G Semenzato; F Herrmann; K H Mills
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  Immuno-phenotype and proliferative response of B-cell chronic lymphocytic leukemia.

Authors:  S Karfa; R Gopal; J S Nadkarni
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

Review 6.  T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?

Authors:  Philipp M Roessner; Martina Seiffert
Journal:  Leukemia       Date:  2020-05-26       Impact factor: 11.528

7.  Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia.

Authors:  S H Swerdlow; L J Murray; J A Habeshaw; A G Stansfeld
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.